Found 48 matching trials
Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia N/A These laboratory trial studies the development and treatment of a mouse mod...
Show More Location
Children's Oncology Group
Learn More & Join Trial
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old PHASE1 A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Show More Location
Hospital Universitario Príncipe de Asturias
Learn More & Join Trial
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML PHASE1 Ziftomenib is an investigational drug in development for the treatment of p...
Show More Location
Mayo Clinic - Phoenix
Learn More & Join Trial
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS PHASE1 This study is being done to evaluate the safety, tolerability and antitumor...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML) PHASE1 The purpose of this study is to define a safe dose of AC220 when given as m...
Show More Learn More & Join Trial
A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants EARLY_PHASE1 The purpose of this study is to investigate the one-way drug-drug interacti...
Show More Location
Worldwide Clinical Trials
Learn More & Join Trial
Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE1 This phase I/II trial studies the side effects and best dose of quizartinib...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
AC220 for Children With Relapsed/Refractory ALL or AML PHASE1 This is a phase I study of the investigational drug AC220 combined with cyt...
Show More Location
Childrens Hospital Los Angeles
Learn More & Join Trial
Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) Mutation PHASE2 This is a Phase 2, multi-center, open-label study to evaluate the efficacy,...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML) PHASE1 The purpose of this study is to define the maximum tolerated dose (MTD) of ...
Show More Location
Mayo Clinic Jacksonville
Learn More & Join Trial